October 8, 2024 10:10 AM EDTUpdated October 11, 09:20 AM
News Briefing

Schol­ar Rock aims to raise $275M; Vin­cerx to reshuf­fle pipeline fo­cus

ENDPOINTS

Plus, news about Vi­core:

Schol­ar Rock seeks $275M in stock sale: Af­ter an­nounc­ing the suc­cess of a piv­otal clin­i­cal tri­al for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times